Date: 6th October, 2026

Scheme of Arrangement Background

The Hon'ble National Company Law Tribunal, Allahabad Bench, Prayagraj sanctioned the Scheme of Arrangement amongst India Glycols Limited (Demerged Company), Ennature Bio Pharma Limited (Resulting Company 1) and IGL Spirits Limited (Resulting Company 2) and their respective shareholders vide order dated 17th July, 2026.

The Scheme provided for demerger, transfer and vesting of Bio Pharma and the Spirits & Biofuel Undertaking(s) in Resulting Company 1 and Resulting Company 2 respectively, on a going concern basis.

The Scheme became effective from 1st September, 2026.

Share Allotment Details

Resulting Company 1 and Resulting Company 2 allotted Equity Shares of ₹5 each to shareholders of India Glycols Limited whose names appeared in the Register of Members maintained by the Depositories as on the Record Date, Wednesday, 2nd September, 2026.

The allotment ratio was:

  • 1 Equity Share of Ennature Bio Pharma Limited (Resulting Company 1) for every 3 Equity Shares held in India Glycols Limited
  • 1 Equity Share of IGL Spirits Limited (Resulting Company 2) for every 1 Equity Share held in India Glycols Limited

Cost Apportionment Guidance

For determining the Cost of Acquisition of Equity Shares following the Demerger, shareholders should apportion the original Cost of Acquisition of their Equity Shares of India Glycols Limited as follows:

| Company | Percentage of Total Cost |

| India Glycols Limited | 31.77% |

| Ennature Bio Pharma Limited | 20.61% |

| IGL Spirits Limited | 47.62% |

Important Disclaimer

The communication is for general guidance only and should not be considered a substitute for independent professional opinion. The Company states that regulatory, statutory or judicial authorities could take a different view. Shareholders are advised to consult their own consultants/tax advisors to understand specific tax implications. The Company takes no express or implied responsibility/liability in relation to this guidance.

Additional Information

The communication is hosted on the Company's website at www.indiaglycols.com.

This disclosure references previous communications bearing numbers IGL/SE/2026-27/58 and IGL/SE/2026-27/59 both dated 8th September, 2026, which intimated about the allotment of equity shares of the Resulting Companies.